Literature DB >> 31386789

A ROCK inhibitor promotes keratinocyte survival and paracrine secretion, enhancing establishment of primary human melanocytes and melanocyte-keratinocyte co-cultures.

Jun Mi1,2, Yang Feng2,3, Jie Wen1, Yiqun Su1,2, Lin Xu1,4, Tingjian Zu1, Chang Liu1, David E Fisher2, Xunwei Wu1,2.   

Abstract

Primary melanocytes isolated from skin and expanded in culture have been widely used for laboratory research and clinical applications. The conventional method to isolate primary melanocytes from skin usually requires about 3-4 weeks of culture for melanocytes to grow sufficiently to passage. Considering that melanocytes comprise only 3%-7% of epidermal cells in normal human skin, it would be extremely helpful to increase the isolation efficiency and shorten the initial culture time to quickly meet various application needs. Here, we report that adding Y-27632, a Rho kinase inhibitor, into the initial culture medium for 2 days can dramatically increase the yield of melanocytes. We found that Y-27632 can promote keratinocyte attachment and survival in the melanocyte culture system, resulting in not only better recovery, but also increased proliferation of melanocytes by a paracrine signaling pathway. More specifically, Y-27632 significantly induced keratinocyte expression of stem cell factor, which played an important role in enhancing the growth of melanocytes. In summary, Y-27632 could profoundly enhance the yield of primary melanocytes in the initial culture through paracrine effects on keratinocytes.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Rho-associated protein kinase; Y-27632; keratinocytes; melanocytes; paracrine signaling

Year:  2019        PMID: 31386789     DOI: 10.1111/pcmr.12816

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  3 in total

1.  Tumour travel tours - Why circulating cancer cells value company.

Authors:  Sophia Julia Häfner
Journal:  Biomed J       Date:  2020-02-24       Impact factor: 4.910

2.  Early-stage bilayer tissue-engineered skin substitute formed by adult skin progenitor cells produces an improved skin structure in vivo.

Authors:  Qun Zhang; Jie Wen; Chang Liu; Chuan Ma; Fuxiang Bai; Xue Leng; Zhihong Chen; Zhiwei Xie; Jun Mi; Xunwei Wu
Journal:  Stem Cell Res Ther       Date:  2020-09-18       Impact factor: 6.832

Review 3.  Ex vivo gene modification therapy for genetic skin diseases-recent advances in gene modification technologies and delivery.

Authors:  Vignesh Jayarajan; Evangelia Kounatidou; Waseem Qasim; Wei-Li Di
Journal:  Exp Dermatol       Date:  2021-03-11       Impact factor: 3.960

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.